7Sumi H,Ohtsu A,Boku N,et al.A case of inoperable esophageal carcinoma with hepatic and nodal metastases which showed a long-term survival after chemoradiotherapy including nedaplatin [J].JpnJ Clin Oncol,2000,30(9):406～409
8Kaneko K,Ito H,Ito T,et al.A case of esophageal carcinoma with multiple liver metastases successfully treated with nedaplatin (NDP) and 5-fluorouracil (5-FU) combined with radiotherapy[J].Gan To Kagaku Ryoho,2001,28(6):831 ～834
9Hirabayashi Y,Okada E.Combination chemotherapy with 254-S,ifosfamide and peplomycin for advanced or recurrent cervical cancer[J].Cancer,1992,71:2769 -2775
10Adachi S,Ogasawara T,Yamasaki N,et al.A pilot study of nedaplatin and etoposide for recurrent gynecological malignancies [J].Oncol Rep,1998,5(4):881-884
4Lee JW, Moon MJ, Min HY, et al. Induction of apoptosis by a novel indirubin-5-nitrc-3'-monoxime, a CDK inhibitor, in human lung cancer cells[J]. Bioorg Med Chem Lett, 2005, 15 (17) : 3948-3952.
5Hammond L A, Eckardt J R, Ganapathi R, et al. A phase I and translational study of sequential administration of the topoimerase I and II inhibitors topotecan and etoposide[J]. Clin Cancer Res, 1998, 4(6): 1459-1467.
6Damiens E, Baratte B, Marie D, et al. Anti-mitotic properties of indirubin-3"-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest [J]. Oncogene, 2001, 20(29) : 3786-3797.
7Perabo FG, FrOssler C, Landwehrs G. Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer[J]. Anticancer Res, 2006 26(3A) : 2129-2135.
8Shi J, Shen HM. Critical role of Bid and Bax in indirubin-3'- monoxime-induced apoptosis in human cancer cells[J]. Biochem Pharmacol, 2008, 75(9): 1729-1742.
9Karmakar S, Banik NL, Ray SK. Curcumin suppressed anti- apoptotic signals and activated cysteine proteases for apoptosis in human malignant glioblastoma U87MG cells[J]. Neurochem Res, 2007, 32(12) :2103-2113.
